Breaking News
Senate Republicans Block Haiti TPS Extension as Haitian Immigrants Face Uncertainty • Former Head of All-Girls School Indicted, Accused of Ignoring Abuse Reports • Kagan Says Supreme Court Has Stood Up to Trump in Key Cases • Amish Shah Wins Democratic Primary in Swing Arizona House District • ICE Contractor Faces Charges in Shooting Outside Colorado Detention Center • What We Know About the Police Shooting in Madison • Quebec band Angine de Poitrine featured in NFL TikTok video • 9 Quebecers share $25M Lotto Max jackpot winnings • Congregation puts Villa Maria domain up for sale, sets conditions to protect college • Democratic Voters Keep Defying the Party Establishment • Senate Republicans Block Haiti TPS Extension as Haitian Immigrants Face Uncertainty • Former Head of All-Girls School Indicted, Accused of Ignoring Abuse Reports • Kagan Says Supreme Court Has Stood Up to Trump in Key Cases • Amish Shah Wins Democratic Primary in Swing Arizona House District • ICE Contractor Faces Charges in Shooting Outside Colorado Detention Center • What We Know About the Police Shooting in Madison • Quebec band Angine de Poitrine featured in NFL TikTok video • 9 Quebecers share $25M Lotto Max jackpot winnings • Congregation puts Villa Maria domain up for sale, sets conditions to protect college • Democratic Voters Keep Defying the Party Establishment •
Live Updates: Haitian Business Spotlight Politics Entertainment Sports Business Haiti News U.S. News Canada News
U.S. News

F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom

Haitian Globe
Author
July 24, 2026
Published
1 min read
Reading time
8
Views
Share:
Embed on your website
F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom

The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.

Advertisement

Via New York Times

Read original article

About the Author

Haitian Globe

Site administrator for Haitian Globe

Sponsored

Comments (0)

Add a Comment

No comments yet